|
Session 1 |
|
What Chinese Life Sciences Companies Need to Know Under US-China Tension |
| April 11, 9:30 pm ET | 12 April 9:30 am CST |
|
Replay of Session 1: May 4, 9:30 pm ET | 5 May 9:30 am CST |
|
Session 2 |
|
Considerations for Cross-Border Strategic Licenses and Collaborations for Asia-Based Life Sciences Companies |
| April 26, 9:30 pm ET | 27 April 9:30 am CST |
|
Session 3 |
|
Introduction to US Intellectual Property |
| May 8, 9:30 pm ET | 9 May 9:30 am CST |
|
Session 4 |
|
Introduction to Life Sciences IP for Chinese Companies |
| May 17, 9:30 pm ET | 18 May 9:30 am CST |
|
Session 5 |
| Piloting Through the Pathways of Employment Law: An Essential Guide for Emerging Companies |
| May 23, 9:30 pm ET| 24 May 9:30 am CST | 24 May 10:30 am JST |
|
Session 6 |
|
FDA’s New Guidance on Clinical Decision Support Software |
| May 29, 9:30 pm ET | 30 May 9:30 pm CST |
|
Session 7 |
|
Investing in Life Sciences Start-ups in the US: Key Issues and Considerations |
| June 6, 9:30 pm ET | 7 June 9:30 am CST |
|
Session 8 |
| US Government Enforcement: Recent Developments and Issues in Investigations |
| June 12, 9:30 pm ET | 13 June 9:30 am CST |
|
Session 9 |
|
International Patent Portfolio Management Strategies for Japanese Companies |
| July 5, 9:30 pm ET | 6 July 9:30 am CST |
